ليست عنوان مقالات لاتين Mycetoma revisited :Incidence of various radiographic signs Myocardial revascularisation after acute myocardial infarction

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Mycetoma revisited :Incidence of various radiographic signs

2

MYCETOMA: A LOCAL EXPERIENCE

3

Mycetoma: A report of 8 cases at tertiary care hospital in Central India with review of literature

4

Mycetozoal bloom in a hydroponic culture of garden cress (Lepidium sativum L.)

5

Mycielski approach for wind speed prediction

6

Myc—Is this the oncogene from Hell?

7

MYCN gain and MYCN amplification in a stage 4S neuroblastoma

8

MYCN Gene Copy Number Status Detected by FISH Method and Its Correlation with Outcome and Clinicopathological Variables in Childhood Neuroblastoma

9

MYCN in neuronal tumours

10

MYCN oncoprotein targets and their therapeutic potential

11

Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation

12

MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells

13

Myco-agro sorbents: novel heavy metal sequesters

14

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

15

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

16

Mycobacteria and sarcoidosis

17

Mycobacteria in the environment of pig farms in the Czech Republic between 2003 and 2007

18

Mycobacteria in water, feedstocks and food: analysis of publications

19

Mycobacteria, but not mercury, induces metallothionein (MT) protein in striped bass, Morone saxitilis, phagocytes, while both stimuli induce MT in channel catfish, Ictalurus punctatus, phagocytes

20

Mycobacteria: Genetics of Resistance and Implications for Treatment

21

Mycobacterial ABC Transport System: Structure of the Primary Phosphate Receptor

22

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

23

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

24

Mycobacterial disease in renal allograft recipients

25

Mycobacterial disease: A historical and epidemiologic perspective

26

Mycobacterial DNA Gyrase: Enzyme Purification and Characterization of Supercoiling Activity

27

Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis

28

Mycobacterial formulation in liposomes showed decreased expression of CD95/CD95L and caspase activity in T cells of leprosy patients

29

Mycobacterial Gene Cloning and Expression, Comparative Genomics, Bioinformatics and Proteomics in Relation to the Development of New Vaccines and Diagnostic Reagents

30

Mycobacterial granulomas: keys to a long-lasting host–pathogen relationship

31

Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma

32

Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study

33

Mycobacterial infections in multiple species: Implications for diagnosis and control

34

Mycobacterial Phenolic Glycolipid Virulence Factor Biosynthesis: Mechanism and Small-Molecule Inhibition of Polyketide Chain Initiation Original Research Article

35

Mycobacterial protein boosts BCG immunity

36

Mycobacteriosis in fishes: A review

37

MYCOBACTERIUM ULCERANS INFECTION (BURULI ULCER): FIRST REPORTED CASE IN A TRAVELER

38

Mycobacterium abscessus in a long-term respiratory care unit

39

Mycobacterium arupense among the isolates of non-tuberculous mycobacteria from human, animal and environmental samples

40

Mycobacterium Avium and Mycobacterium intracellulare Infections in Slaughtered Pigs in Makurdi, North-Central Nigeria: An Emerging Zoonosis

41

Mycobacterium avium Complex Extracellular Vesicles Attenuate Inflammation via Inducing IL-10

42

Mycobacterium avium subsp. avium in domestic pigeons (Columba livia f. domestica) diagnosed by direct conventional multiplex PCR: a case report

43

Mycobacterium avium subsp. Paratuberculosis in a mouflon herd without clinical symptoms monitored using IS900 real-time PCR: a case report

44

Mycobacterium avium subsp. paratuberculosis in muscle, lymphatic and organ tissues from cows with advanced Johneʹs disease

45

Mycobacterium avium subsp. paratuberculosis induces differential cytosine methylation at miR-21 transcription start site region

46

Mycobacterium avium subsp. paratuberculosis survival during fermentation of soured milk products detected by culture and quantitative real time PCR methods

47

Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease

48

Mycobacterium Avium Subspecies Paratuberculosis Multibacillary Infection (Johne’s disease) ina Teddy Goat

49

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

50

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

51

Mycobacterium avium subspecies paratuberculosis: A possible causative agent in human morbidity and risk to public health safety

52

Mycobacterium avium subspecies paratuberculosis: the nature of the problem

53

Mycobacterium avium subspecies paratuberculosisA Review of Present Research in Norway

54

Mycobacterium aviumComplex Activates Nuclear Factor κB via Induction of Inflammatory Cytokines

55

Mycobacterium aviumReduces Expression of Costimulatory/Adhesion Molecules by Human Monocytes

56

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

57

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

58

Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates human β-defensin-2 gene transcription in human epithelial cells

59

Mycobacterium bovis Bacillus Calmette–Guérin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells

60

Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells

61

Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced CXCL8 production is mediated through PKCα-dependent activation of the IKKαβ signaling pathway in epithelial cells

62

Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection

63

Mycobacterium bovis BCG induces CXC chemokine ligand 8 secretion via the MEK-dependent signal pathway in human epithelial cells

64

Mycobacterium bovis BCG Toll-Like Receptors 2 and 4 Cooperation Increases the Innate Epithelial Immune Response

65

Mycobacterium bovis BCG vaccine induces non-specific immune responses in Japanese flounder against Nocardia seriolae

66

Mycobacterium bovis in Korea: An update

67

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

68

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

69

Mycobacterium bovis infection in domestic pigs in Great Britain

70

Mycobacterium bovis infection: Everything but the cow

71

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: Review of epidemiology and laboratory submissions in Great Britain 2004–2010

72

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 2: A review of diagnostic methods

73

Mycobacterium bovis tuberculins: Preparation and antigenic properties

74

Mycobacterium bovis tuberculosis: forgotten, but not gone

75

Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical administration of bacille Calmette-Guérin

76

Mycobacterium bovis: guidance on BCG vaccination is needed

77

Mycobacterium boviss Infection and Tuberculosis in Cattle

78

Mycobacterium chelonae interface infection after endokeratoplaty

79

Mycobacterium chelonae keratiti after laer in itu keratomileui uccefully treated with medical therapy and flap removal

80

Mycobacterium chelonae Keratitis Following Laser in situ Keratomileusis (LASIK) Specifically Identified by INNO-LIPA Method

81

Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms

82

Mycobacterium fortuitum-induced surgical wound infection - a case report

83

Mycobacterium gordonae in fiberoptic bronchoscopes

84

Mycobacterium leprae-induced demyelination: a model for early nerve degeneration

85

Mycobacterium marinum

86

Mycobacterium marinum as a cause of skin chronic granulomatous in the hand

87

Mycobacterium marinum hand infection: case reports and review of literature

88

Mycobacterium Marinum Infection after Infliximab Therapy

89

Mycobacterium marinum infection: A case report

90

Mycobacterium mucogenicum and Klebsiella pneumoniae Pulmonary Infection in a Patient Following Cardiac Surgery: A Case Report

91

Mycobacterium mucogenicum causing central line-related sepsis in a home parenteral nutrition patient

92

Mycobacterium mucogenicum meningitis due to external ventricular drain

93

Mycobacterium paratuberculosis and Milk

94

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

95

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

96

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

97

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

98

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

99

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

100

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

101

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

102

Mycobacterium simiae Isolates Subtypes and Molecular Drug Susceptibility in Iran

103

Mycobacterium Strain and Type of Resistance in Pulmonary Tuberculosis Patients: A Missed Link in Iran’s National Tuberculosis Plan

104

Mycobacterium Thermoresistibile Infection in a Child

105

Mycobacterium tuberculosis alters the differentiation of monocytes into macrophages in vitro

106

Mycobacterium tuberculosis and bovis as causes for shrinking bladder

107

Mycobacterium tuberculosis and Cryptococcus neoformans co-infection meningitis in a young immuncompetent woman

108

Mycobacterium tuberculosis and Dual M. tuberculosis/M. bovis Infection as the Cause of Tuberculosis in a Gorilla and a Lioness, Respectively, in Ibadan Zoo, Nigeria

109

Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence

110

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

111

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

112

Mycobacterium tuberculosis and pemphigus vulgaris

113

Mycobacterium Tuberculosis Breast Infection Mimicking Pyogenic Abscesses in Kuwait

114

Mycobacterium tuberculosis Detection based on mpt64 amplification by Nested-PCR in Sputum samples

115

Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso

116

Mycobacterium tuberculosis genome sequence illuminates bugʹs biology

117

Mycobacterium tuberculosis GroEL Homologues Unusually Exist as Lower Oligomers and Retain the Ability to Suppress Aggregation of Substrate Proteins

118

Mycobacterium tuberculosis H37Rv3377c encodes the diterpene cyclase for producing the halimane skeleton

119

Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis

120

Mycobacterium tuberculosis Hsp16.3 Nonamers are Assembled and Re-assembled via Trimer and Hexamer Intermediates

121

Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli

122

Mycobacterium tuberculosis infection and FHIT gene alterations in lung cancer

123

Mycobacterium tuberculosis infection in grazing cattle in central Ethiopia

124

Mycobacterium tuberculosis infection in travellers: tuberculosis comes home

125

Mycobacterium tuberculosis infection in women with unexplained infertility

126

Mycobacterium tuberculosis infection presenting with cutaneous abscess and osteomyelitis

127

Mycobacterium Tuberculosis Infection: Participation of TH1, TH2, TH17 and Regulatory T Cells in the Immune Response

128

Mycobacterium tuberculosis Inhibits MHC Class II Antigen Processing in Murine Bone Marrow Macrophages

129

Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation

130

Mycobacterium tuberculosis Protein Tyrosine Phosphatase PtpB Structure Reveals a Diverged Fold and a Buried Active Site

131

Mycobacterium tuberculosis Ribose-5-phosphate Isomerase has a Known Fold, but a Novel Active Site

132

Mycobacterium tuberculosis spoligotypes circulating in the Lebanese population: a retrospective study

133

Mycobacterium tuberculosis Thymidylate Kinase: Structural Studies of Intermediates along the Reaction Pathway

134

Mycobacterium tuberculosis transmission and HIV status

135

Mycobacterium tuberculosis transmission and HIV status

136

Mycobacterium tuberculosis transmission and HIV status

137

Mycobacterium tuberculosis β-ketoacyl-ACP reductase: α-Secondary kinetic isotope effects and kinetic and equilibrium mechanisms of substrate binding

138

Mycobacterium tuberculosis: a stowaway in the cell

139

Mycobacterium tuberculosisComplex DNA in Ancient Human Bones

140

Mycobacterium ulcerans

141

Mycobacterium ulcerans disease (Buruli ulcer) following human bite

142

Mycobacterium ulcerans infection Review Article

143

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial

144

Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak

145

Mycobial enhancement of ergothioneine by submerged cultivation of edible mushroom mycelia and its application as an antioxidative compound

146

Mycobiota and aflatoxin B1 contamination of Piper guineense (Ashanti pepper), P. nigrum L. (black pepper) and Monodora myristica (calabash nutmeg) from Lagos, Nigeria

147

Mycobiota and aflatoxin B1 contamination of rainbow trout(Oncorhinchus mykiss) feed with emphasis toAspergillus section Flavi

148

Mycobiota and co-occurrence of mycotoxins in Capsicum powder

149

Mycobiota and identification of aflatoxin gene cluster in marketed spices in West Africa

150

Mycobiota and mycotoxin contamination of maize flours and popcorn kernels for human consumption commercialized in Spain Original Research Article

151

Mycobiota and mycotoxin producing fungi from cocoa beans

152

Mycobiota and mycotoxins in Brazil nut samples from different states of the Brazilian Amazon region

153

Mycobiota and mycotoxins in Brazilian peanut kernels from sowing to harvest

154

Mycobiota and mycotoxins present in finished fish feeds from farms in the Rio de Janeiro State, Brazil

155

Mycobiota and natural occurrence of aflatoxin, deoxynivalenol, nivalenol and zearalenone in rice freshly harvested in South Korea

156

Mycobiota and Toxigenecity Profile of Aspergillus flavus Recovered from Food and Poultry Feed Mixtures in Cameroon

157

Mycobiota associated with larval mines of Thrypticus truncatus and T. sagittatus (Diptera, Dolichopodidae) on waterhyacinth, Eichhornia crassipes, in Argentina

158

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

159

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

160

Mycobiota in the processing areas of two different meat products

161

Mycobiota of cocoa: From farm to chocolate Original Research Article

162

Mycobiota of the arid Middle East: check-list of novel fungal taxa introduced from 1940 to 2000 and major recent biodiversity titles

163

Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome

164

Mycoediketopiperazine, a novel fungal metabolite from a Papularia sp.

165

Mycoflora and absence of aflatoxin contamination of commercialized cassava chips in Benin, West Africa

166

Mycoflora and mycotoxins in field samples of Brazil nuts

167

Mycoflora and natural occurrence of aflatoxins and fumonisin B1 in cassava and yam chips from Benin, West Africa

168

Mycoflora and nutritional components of cocoa powder samples in South West Nigeria

169

Mycoflora and occurrence of aflatoxin in dried vegetables in Benin, Mali and Togo, West Africa

170

Mycoflora and ochratoxin A producing strains of Aspergillus in Algerian wheat

171

Mycoflora and Water Quality index Assessment of Water Sources in Oproama, Niger Delta, Nigeria

172

Mycoflora associated with cucurbits

173

Mycoflora Associated with Some Textiles in Jeddah City

174

Mycoflora associated with stored seeds of soybean

175

Mycoflora associated with tomato during the process of marketing

176

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

177

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

178

Mycoflora of human external auditory canal in Shiraz, southern Iran

179

Mycoflora of Ostrich (Struthio camelus) gastrointestinal tract as a human hazard

180

Mycoflora of paddy and milled rice produced in the region of Northeastern Argentina and Southern Paraguay

181

Mycoflora of pistachio and peanut kernels from Sari, Iran

182

Mycoflora of pistachio and peanut kernels from Sari, Iran

183

Mycoflora of the Interdigital Spaces Among Girl Students in Ahvaz, Iran

184

Mycogenesis of cerium oxide nanoparticles using Aspergillus niger culture filtrate and their applications for antibacterial and larvicidal activities

185

Mycogenesis of silver nanoparticles by different Aspergillus species

186

Mycogenic nanoparticles and their bio‑prospective applications: current status and future challenges

187

Myco-heterotroph/epiparasitic plant interactions with ectomycorrhizal and arbuscular mycorrhizal fungi

188

Mycohydrometallurgy: Biotransformation of double refractory gold ores by the fungus, Phanerochaete chrysosporium

189

Myco-hydrometallurgy: Coal model for potential reduction of preg-robbing capacity of carbonaceous gold ores using the fungus, Phanerochaete chrysosporium

190

Mycoinsecticides and Mycoacaricides: A comprehensive list with worldwide coverage and international classification of formulation types

191

Mycolactones and Mycobacterium ulcerans disease

192

Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis Original Research Article

193

Mycolic Acids Constitute a Scaffold for Mycobacterial Lipid Antigens Stimulating CD1-Restricted T Cells Original Research Article

194

Mycological and histopathological findings of experimental disseminated candidiasis in dogs

195

Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts

196

Mycological assessment of sediments in Ligurian beaches in the Northwestern Mediterranean: Pathogens and opportunistic pathogens

197

Mycological Evaluation of Imported Frozen Fish

198

Mycological evaluation of the phylloplane of Vigna unguiculata (L.) Walp

199

Mycological Identification of Some Fungi Isolated from Meat Products and Spices with Molecular Identification of Some Penicillium Isolates

200

Mycological investigation in patients with acute otitis media

201

Mycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples

202

Mycological quality and mycotoxin contamination of Sri Lankan peppers (Piper nigrum L.) and subsequent exposure assessment

203

Mycological Study of Superficial-cutaneous Mycoses in Tehran, Iran

204

Mycological Survey and Total Aflatoxin Analyze in Silage from Qaemshahr City (Northern Iran)

205

Mycological survey of ripped service tree fruits (Sorbus domestica L.) with an emphasis on toxinogenic fungi

206

Mycoparasitism of Ampelomyces quisqualis Ces. ex Schlecht on Powdery Mildew Fungi in Syria

207

Mycoparasitism of Pythium ultimum by Antagonistic Binucleate Rhizoctonia Isolates in Agar Media and on Capsicum Seeds

208

Mycoparasitism of Rhizoctonia solani by Endophytic Chaetomium spirale ND35: Ultrastructure and Cytochemistry of the Interaction

209

Mycophenolate mofetil

210

Mycophenolate mofetil - a new treatment for autoimmune hepatitis?

211

Mycophenolate Mofetil (MMF) Efficacy in Glomerulonephritis (GN), a Retrospective Analysis

212

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders

213

Mycophenolate Mofetil Ameliorates Perivascular T Lymphocyte Inflammation and Reduces the Double-Negative T Cell Population in SLE-Prone MRLlpr/lpr Mice

214

Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum

215

Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome

216

Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation

217

Mycophenolate mofetil for Crohnʹs disease?

218

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine

219

Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation

220

Mycophenolate mofetil for prevention of acute rejection

221

Mycophenolate mofetil for severe autoimmune haemolytic anemia

222

Mycophenolate mofetil for systemic vasculitis and IgA nephropathy

223

Mycophenolate Mofetil for the Treatment of Uveiti Original Reearch Article

224

Mycophenolate mofetil for transplantation: new drug, old problems?

225

Mycophenolate Mofetil for Treatment of Idiopathic Nephrotic Syndrome in Children

226

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome

227

Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: a preliminary study

228

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C

229

Mycophenolate mofetil in Crohnʹs disease

230

Mycophenolate mofetil in IBD patients

231

Mycophenolate Mofetil in Low Doses Stabilizes and Improves Antineutrophil Cytoplasmic Antibody-associated Vasculitis and Lupus Nephritis

232

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

233

Mycophenolate mofetil monotherapy in liver transplantation

234

Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis

235

Mycophenolate mofetil to rescue children with acute renal transplant rejection

236

Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit

237

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

238

Mycophenolate mofetil versus cyclophosphamide for therapy of lupus nephritis: an evidence-based case report from systematic reviews and metaanalyses

239

Mycophenolate Mofetil versus Cyclosporine in Children with Frequent Relapse Nephrotic Syndrome

240

Mycophenolate mofetil: a new therapeutic option in dermatology

241

Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases?

242

Mycophenolate Mofetil; A Review of Indications and Use in a Large Tertiary Hospital

243

Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients

244

Mycophenolate Sodium versus Mycophenolate Mofetil: A Review of Their Comparative Features

245

Mycophenolic acid analogs with a modified metabolic profile Original Research Article

246

Mycophenolic acid as a latent agonist of PPARγ

247

Mycophenolic Acid Concentration on Vietnamese Renal Transplant Recipients

248

Mycophenolic Acid Influences T Helper 2 (Th2) Cytokine Induced Expression of Intercellular Cell Adhesion Molecule-1 (ICAM-1) on Human Endothelial Cells

249

Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages

250

Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145

251

Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation

252

Mycoplasma bovis and otitis in dairy calves in the United Kingdom

253

Mycoplasma bovis Infection with Enzootic Pneumonia Symptoms in a Beef Cattle Farm

254

Mycoplasma bovis-associated disease: Here, there and everywhere

255

Mycoplasma capricolum subsp. capripneumoniae, the cause of contagious caprine pleuropneumonia, comprises two distinct biochemical groups

256

Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders

257

Mycoplasma genitalium and Mycoplasma hominis infection in south Korea during 2018-2020

258

Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome

259

Mycoplasma hominis infections occurring in cardiovascular surgical patients

260

Mycoplasma hominis parasitism of Trichomonas vaginalis

261

Mycoplasma hominis parasitism of Trichomonas vaginalis

262

Mycoplasma hominis parasitism of Trichomonas vaginalis

263

Mycoplasma host specificity: Fact or fiction?

264

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

265

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

266

Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling

267

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

268

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

269

Mycoplasma Infection in Pyospermic Infertile and Healthy Fertile Men

270

Mycoplasma Infection in the Lungs of Cattle: The First Identification of Mycoplasma dispar in Iran

271

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

272

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

273

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia

274

Mycoplasma pneumonia in Cerebrospinal Fluids of Febrile Children With Neurologic Manifestations: A Cross Sectional Study, Tehran, Iran

275

Mycoplasma pneumonia infection and asthma: A clinical study

276

Mycoplasma pneumoniae and Recurrent Respiratory Tract Infection Within One Year After Treatment in Infants: Risk Factors and Prevalence

277

Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia

278

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report

279

Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis

280

Mycoplasma pneumoniae Infection Among Children: A Systematic Review and Meta-analysis of Published Literature

281

Mycoplasma Pneumoniae Infection with Neurologic Complications

282

Mycoplasma pneumoniae pneumonia following assisted ventilation

283

Mycoplasma pneumoniae preceding Lemierre’s syndrome due to Fusobacterium nucleatum complicated by acute Epstein–Barr virus (EBV) infectious mononucleosis in an immunocompetent host

284

Mycoplasma Synoviae and other Associated Bacteria Causing Arthritis in Chicken

285

Mycoplasma wenyonii: A Causative Agent of New Mastitis in Dairy Cows

286

Mycoplasma-like organisms in Hodgkinʹs disease

287

Mycoplasma-pneumoniae-Induced Thrombotic Thrombocytopenic Purpura

288

Mycoplasmas – Identifying hosts for a stealth pathogen

289

Mycoplasmas and oncogenesis

290

Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections

291

Mycoplasmoses of ruminants in France: recent data from the national surveillance network

292

Mycoplasmosis in Slaughtered She-Camels: Pathological Studies

293

Mycoprotein Production from Date Waste Using Fusarium venenatum in a Submerged Culture

294

Myco-remediation of Dairy Wastewater by Naturally Attenuated Aspergillus sp. Responsible for Sulfate Reduction

295

Mycoremediation of Dichlorvos Pesticide Contaminated Soil by Pleurotus pulmonarius (Fries) Quelet

296

Mycorrhiza between Kobresia bellardii (All.) Degel and Terfezia boudieri Chatin

297

Mycorrhiza formation is not needed for early growth induction and growth-related changes in polyamines in Scots pine seedlings in vitro

298

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

299

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

300

Mycorrhizae confer aluminum resistance to tulip-poplar seedlings

301

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

302

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

303

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

304

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

305

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

306

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

307

Mycorrhiza-induced resistance: more than the sum of its parts?

308

Mycorrhiza-induced resistance: more than the sum of its parts?

309

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

310

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

311

MYCORRHIZAL ASSOCIATION IN SOME WEEDS OF curcuma longa FIELDS OF DISTRICT KASUR, PAKISTAN

312

Mycorrhizal association of maritime pine, Pinus pinaster, with Rhizopogon roseolus has contrasting effects on the uptake from soil and root-to-shoot transfer of 137Cs, 85Sr and 95mTc

313

Mycorrhizal colonisation improves fruit yield and water use efficiency in watermelon (Citrullus lanatus Thunb.) grown under well-watered and waterstressed conditions

314

Mycorrhizal colonization and nitrogen uptake by maize: combined effect of tropical earthworms and velvetbean mulch

315

Mycorrhizal colonization of major banana genotypes in six East African environments

316

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

317

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

318

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

319

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

320

Mycorrhizal dependency of Chihuahuan Desert plants is influenced by life history strategy and root morphology

321

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

322

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

323

Mycorrhizal evolution

324

Mycorrhizal fungi biodiversity in Canadian soils

325

Mycorrhizal fungi enhance accumulation and tolerance of chromium in sunflower (Helianthus annuus)

326

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

327

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

328

MYCORRHIZAL FUNGUS (GLOMUS MOSSAE) INOCULATION EFFECTS ON PERFORMANCE AND ROOT BIOMASS DEVELOPMENT OF CACAO SEEDLINGS IN THE NURSERY

329

Mycorrhizal impact on osmotic adjustment in Ocimum basilicum during a lethal drying episode

330

Mycorrhizal networks: des liaisons dangereuses?

331

Mycorrhizal phosphorus enhancement of plants in undisturbed soil differs from phosphorus uptake stimulation by arbuscular mycorrhizae over non-mycorrhizal controls

332

Mycorrhizal protection of chili plants challenged by Phytophthora capsici

333

Mycorrhizal symbiosis and response of sorghum plants to combined drought and salinity stresses

334

Mycorrhizal symbiosis effects on growth of chalk false-brome (Brachypodium pinnatum) are dependent on the environmental light regime

335

Mycorrhizas and tropical soil fertility

336

MYCORRHIZATION AND USE OF SUPERABSORBENT POLYMERS IN TARGETED PRODUCTION OF HARDWOODS PLANTING MATERIAL

337

Mycorrhization of fossil and living plants

338

Mycorrhization of the notabilis and sitiens tomato mutants in relation to abscisic acid and ethylene contents

339

Mycosis fungoides and alopecia areata: A case report

340

Mycosis fungoides and Sézary syndrome

341

Mycosis fungoides during the COVID-19 pandemic: a teledermatology study

342

Mycosis Fungoides of the True Vocal Cord: A Case Report and Review of the Literature

343

Mycosis Fungoides Skin Wound Management With Skin Graft Post Ultraviolet Radiation therapy

344

Mycosis fungoides with an unusual clinicopathological presentation

345

Mycosphaerella graminicola produces a range of cell wall-degrading enzyme activities in vitro that vary with the carbon source

346

Mycosphaerella species associated with leaf disease of Eucalyptus globulus in Ethiopia

347

Mycosphaerella species occurring on Eucalyptus globulus and Eucalyptus nitens plantations of Tasmania, Australia

348

Mycosporine-like amino acid composition of the edible red alga, Palmaria palmata (dulse) harvested from the west and east coasts of Grand Manan Island, New Brunswick

349

Mycosporine-like amino acids (MAAs) protect against UV-B-induced damage in Gyrodinium dorsum Kofoid

350

Mycosporine-like amino acids in the marine dinoflagellate Gyrodinium dorsum: induction by ultraviolet irradiation

351

Mycosporine-like amino acids in the marine red alga Gracilaria cornea - effects of UV and heat

352

Mycosynthesis and characterization of selenium nanoparticles using standard penicillium chrysogenum PTCC 5031 and their antibacterial activity: A novel approach in microbial nanotechnology

353

Mycosynthesis of Silver Nanoparticles by Candida albicans Yeast and its Biological Applications

354

Mycosynthesis: Antibacterial, antioxidant and antiproliferative activities of silver nanoparticles synthesized from Inonotus obliquus (Chaga mushroom) extract

355

Mycotic Aneurysm of External Carotid Artery following Traumatic Brain Injury: Case Report and Review of Literature

356

Mycotic aneurysm of superior mesenteric artery branch presenting as pulsatile abdominal mass

357

Mycotic aneurysm of the aorta: Evolving surgical concept

358

Mycotic Aneurysm of the Descending Thoracic Aorta in a 2-kg Neonate

359

Mycotic Aneurysm of the Left Coronary Artery

360

Mycotic aneurysm of the left main coronary artery producing acute coronary occlusion and purulent pericarditis

361

Mycotic Aneurysm of the Thoracic Aorta Caused by Clostridium septicum

362

Mycotic aneurysm presenting as Pancoastʹs syndrome in an injection drug user

363

Mycotic aneurysm: A diagnostic challenge

364

Mycotic aneurysms of the abdominal aorta

365

Mycotic aneurysms of the thoracic aorta: a diagnostic challenge

366

Mycotic aortic aneurysm as a postsurgical complication: report of a case and review of the literature

367

Mycotic Aortic Aneurysm: Review of the Literature and Report of Two Cases

368

Mycotic Aortocoronary Saphenous Vein Graft Aneurysm Presenting With Unstable Angina Pectoris

369

Mycotic arch aneurysm and aortoesophageal fistula in a patient with melioidosis

370

Mycotic Coronary Artery Aneurysm From Fungal Prosthetic Valve Endocarditis

371

Mycotic false aneurysm of the ascending aorta

372

Mycotic infections in diabetic foot ulcers in Emam Reza hospital, Mashhad, 2006-2008

373

Mycotic infections in diabetic foot ulcers in Emam Reza hospital,Mashhad, 2006-2008

374

Mycotic Keratitis, a State-of-the-Art Review

375

Mycotic pseudoaneursym of the aortic arch: an unusual complication of invasive pulmonary aspergillosis

376

Mycotic pulmonary artery aneurysm diagnosed 18 years after bacterial endocarditis

377

Mycotoxicoses in veterinary medicine: Aspergillosis and penicilliosis

378

Mycotoxicosis in Swine: a Review

379

Mycotoxigenic and Proteolytic Potential of Moulds Associated with Smoked Shark Fish (Chlamydoselachus anguincus)

380

Mycotoxigenic Fusarium species in animal feed

381

Mycotoxin analyses in some home produced eggs in Belgium reveal small contribution to the total daily intake

382

Mycotoxin Contaminating Maize and Grass Silages for Dairy Cattle Feeding: Current State and Challenges

383

Mycotoxin Contamination of Foodstuffs and Feedstuffs in Iran

384

Mycotoxin Contamination of Maize Grains Grown in Karnataka (India)

385

Mycotoxin contamination of the feed supply chain: Implications for animal productivity and feed security

386

Mycotoxin content of organic and conventional oats from southeastern Poland

387

Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies

388

Mycotoxin Genetics and Gene Clusters

389

Mycotoxin glucosylation in commercial wheat varieties: Impact on resistance to Fusarium graminearum under laboratory and field conditions

390

Mycotoxin Management in Agriculture: a Review

391

Mycotoxin management in the European cereal trading sector

392

Mycotoxin occurrence in beer produced in several European countries

393

Mycotoxin occurrence in corn meal and flour traded in São Paulo, Brazil

394

Mycotoxin problem in Africa: Current status, implications to food safety and health and possible management strategies

395

Mycotoxin Production and Molecular Variability of European and American Isolates of Fusarium Culmorum

396

Mycotoxin production by Alternaria alternata strains isolated from red delicious apples in Argentina

397

Mycotoxin production by Alternaria strains isolated from Argentinean wheat

398

Mycotoxin production by Aspergillus, Fusarium and Penicillium species

399

Mycotoxin production by isolates of Fusarium lactis from greenhouse sweet pepper (Capsicum annuum)

400

Mycotoxin production in major crops as influenced by growing, harvesting, storage and processing, with emphasis on the achievement of Food Safety Objectives

401

Mycotoxin production of selected Fusarium species at different culture conditions

402

Mycotoxin protocols: Mary W. Trucksess and Albert E. Pohland (Eds.), Methods in Molecular Biology Inc., Volume 157, John M. Walker, Series Editor, Humana Press, Totowa, New Jersey 07512; 2000; hardback, pp xii+ 244; US$79.50; ISBN 0-089603-623-5; Website:

403

Mycotoxin Regulations for Foods: A Global Update

404

Mycotoxin research and mycoflora in some commercially important agricultural commodities

405

Mycotoxin risk evaluation in feeds contaminated by Aspergillus fumigatus

406

Mycotoxin-degradation profile of Rhodococcus strains

407

Mycotoxin-producing potential of fungi isolated from amaranth seeds in Argentina

408

409

Mycotoxins and food safety.: J.W. DeVries, M.W. Trucksess, L.S. Jackson (Eds.), 2002, Vol. 504, Advances in Experimental Medicine and Biology. Kluwer Academic, New York. 295+xi pp. ISBN 0-306-46780-1. Price?

410

Mycotoxins and food safety: Editors: Jonathan W. Devries, Mary W. Trucksess, and Lauren S. Jackson. Advances in Experimental Medicine and Biology, Vol. 504. Kluwer Academic, New York; xi+295 pp.; hardback, EUR 148.00/USD 135.00/GBP 94.00; ISBN 0-306-46780

411

Mycotoxins and phycotoxins. Advances in determination, toxicology and exposure management

412

Mycotoxins and Phycotoxins: Advances in Determination, Toxicology and Exposure Management, H. Njapeu, S. Trujillo, H. van Egmond, D. Pard (Eds.). Wageningen Academic Publishers (2006), ISBN: 978-90-8686-007-4

413

MYCOTOXINS AND SURFACE AND INTERNAL FUNGI OF MAIZE FROM ETHIOPIA

414

Mycotoxins and the pet food industry: Toxicological evidence and risk assessment

415

Mycotoxins and their effects on human and animal health

416

Mycotoxins Contamination in Tea and Herbal Infusion: A Mini-Review

417

Mycotoxins in a changing global environment – A review

418

Mycotoxins in Agriculture and Food Safety. K. K. Sinha and D. Bhatnagar (eds). 15.5 × 23.4 cm, 520 pp. New York, USA: Marcel Dekker [ http://www.dekker.com], 1998. $175. ISBN 0824701925 (hardback).

419

Mycotoxins in Brazilian corn for animal feed: occurrence and incentives for the private sector to control the level of contamination

420

Mycotoxins in cereals and cereal products in Slovenia – Official control of foods in the years 2008–2012

421

Mycotoxins in edible tree nuts

422

Mycotoxins in food from Jordan: Preliminary survey

423

Mycotoxins in food products available in Qatar

424

Mycotoxins in Food. Detection and Control, N. Magan, M. Olsen (Eds.). Woodhead Publishing Limited, Boca Raton, Boston, New York, Washington, DC, Cambridge (2004), ISBN: 1-85573-7337

425

Mycotoxins in fruits and their processed products: Analysis, occurrence and health implications

426

Mycotoxins in myelopathies of man

427

Mycotoxins in rice

428

Mycotoxins in Silages: Occurrence and Prevention

429

Mycotoxins in two Spanish cheese varieties

430

Mycotoxins occurrence in Argentina’s maize (Zea mays L.), from 1999 to 2010

431

Mycotoxins of Aspergilius fumigatus in pure culture and in native bioaerosols from compost facilities

432

Mycotoxins produced by Fusarium genus in maize: determination by screening and confirmatory methods based on liquid chromatography tandem mass spectrometry

433

Mycotoxins Produced by Fusarium spp. in Isogenic Bt vs. non-Bt Maize Hybrids under European Corn Borer Pressure

434

Mycotoxins: Occurrence, toxicology, and exposure assessment

435

Mycotoxins’ Toxicities - from Consumer Health Safety Concerns, to Mitigation/Treatment Strategies: A Perspective Review

436

Mycotrienins: A new class of potent inhibitors of osteoclastic bone resorption

437

MYCOTROPHIC STRATEGY OF 13 COMMON NEOTROPICAL TREES AND SHRUBS

438

Myctophid feeding ecology and carbon transport along the northern Mid-Atlantic Ridge

439

MyD88 pathway is involved in IL-18-mediated increase in intestine matrix metalloproteinase-9

440

Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round

441

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases

442

Myelin Basic Protein is Down-Regulated in Sheep Affected with Ovine Coenurosis

443

Myelin basic protein—diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis

444

Myelin basic protein–lipid complex: an atomic force microscopy study

445

Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases

446

Myelin breakdown in Alzheimer’s disease: a commentary

447

Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men

448

Myelin characterization of fetal brain with mono-point estimated T1-maps

449

Myelin enhancement of Multiple sclerosis model with gold nanoparticles into the corpus callosum

450

Myelin Formation and Remodeling

451

Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination

452

Myelin glycoproteins targeted by lead in the rodent model of prolonged exposure

453

Myelin growth and coiling

454

Myelin Is a Preferential Target of Aluminum-Mediated Oxidative Damage

455

Myelin Membrane Wrapping of CNS Axons by PI(3,4,5)P3-Dependent Polarized Growth at the Inner Tongue

456

Myelin peptides in multiple sclerosis

457

Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice

458

Myelin Proteolipid Protein-Induced Th1 and Th2 Clones Express TCR with Similar Fine Specificity for Peptide and CDR3 Homology Despite Diverse Vβ Usage

459

Myelin-Basic Protein-reactive Specific CD4+ and CD8+ NK Lymphocytes Induce Morphological Changes in Neuronal Cell Bodies and Myelin Sheaths: Implications for Multiple Sclerosis

460

Myelin-like protrusions of giant phospholipid vesicles prepared by electroformation

461

Myelin-Liposome Protection against Experimental Autoimmune Encephalomyelitis Is Associated with Reduced Neuroantigen-Specific T-Cell-Mediated Responses

462

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders

463

Myelin-reactive antibodies mediate the pathology of MBP–PLP fusion protein MP4-induced EAE

464

Myelitis due to enterovirus in patient on interferon therapy for chronic hepatitis B: Case report

465

Myeloablative and immunosuppressive properties of treosulfan in mice

466

Myelodysplasia and Mast Cell Leukemia with t(9;22)

467

Myelodysplasia or Myeloneoplasia: Thoughts on the Nosology of Clonal Myeloid Diseases

468

Myelodysplasia with der(1;7)(q10;p10) discovered after an episode of bacterial lymphangitis in a twenty-three-year-old man

469

Myelodysplasia: The good, the fair and the ugly

470

Myelodysplasia: When to treat and how

471

Myelodysplasia-Like Syndrome and End-Stage Liver Disease

472

Myelodysplasic syndromes: A comprehensive review

473

Myelodysplastic features and cellular senescence in autoimmune disorders: a pilot study on patients with collagen tissue disorders and immune thrombocytopenic purpura

474

Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13)

475

Myelodysplastic Syndrome after Regression of Transient Abnormal Myelopoiesis in a Down Syndrome Infant: Different Clonal Origin?

476

Myelodysplastic syndrome and a nonrandom chromosomal abnormality t(1;19):: an indolent pathologic entity

477

Myelodysplastic syndrome and aortic valve replacement: additions

478

Myelodysplastic Syndrome Associated with Monosomy 7 in a Child with Bloom Syndrome

479

Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study

480

Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype

481

Myelodysplastic syndrome in an infant: induction of remission by cyclosporin

482

Myelodysplastic Syndrome Manifesting As Sweet’s Syndrome and Brochiolitis Obliterative Organizing Pneumonia

483

Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q

484

Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature

485

Myelodysplastic Syndrome with Atypical Eosinophilia in Association with Ring Chromosome 7: A Case Report

486

Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy

487

Myelodysplastic Syndrome with Clonal Eosinophilia Accompanied by Eosinophilic Pulmonary Interstitial Infiltration

488

Myelodysplastic Syndrome with Hypereosinophilia and a Nonrandom Chromosomal Abnormality dic(1;7): Confirmation of Eosinophil Clonal Involvement by Fluorescence In Situ Hybridization

489

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma

490

Myelodysplastic syndrome with monosomy 7 in a patient with XY gonadal dysgenesis (incomplete testicular feminization)

491

Myelodysplastic syndrome with transformation to AML-M7 in a 46,XX male patient

492

Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring

493

Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing

494

Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change

495

Myelodysplastic Syndromes With Nephrotic Syndrome

496

Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease

497

Myelofibrosis in a 24-Year Old Nigerian

498

Myelofibrosis with myeloid metaplasia: Disease overview and non-transplant treatment options

499

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

500

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

501

Myelographic Applications in Newborn Healthy and Paraplegic Calves

502

Myeloid Antigen-positive T Cell Acute Lymphocytic Leukemia with t(14;18) and Trisomy 10: Report of a Case and Literature Review

503

Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia

504

Myeloid Cell Leukemia-1 Gene Expression and Clinicopathological Features in Myelodysplastic Syndrome

505

Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model

506

Myeloid cell trafficking and tumor angiogenesis

507

Myeloid differentiation (MyD) primary response genes in hematopoiesis

508

Myeloid differentiation in long term culture of human peripheral blood

509

Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling

510

Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo

511

Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs

512

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

513

Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice

514

Myeloid Sarcoma after Allogenic Stem Cell Transplantation forAcute Myeloid Leukemia: Successful Consolidation TreatmentApproaches in Two Patients

515

Myeloid sarcoma of the orbit

516

Myeloid Sarcoma of the peritoneum at older ages: A case report and review of literature

517

Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization

518

Myeloid Sarcoma Presenting as Rectosigmoid Tumour: A Case Report

519

Myeloid Sarcoma Presenting with Lateral Cervical Mass and Eosinophilia; a Diagnostic and Therapeutic Dilemma: Case Report

520

Myeloid Sarcoma: Case Series with Unusual Locations

521

Myeloid/natural killer cell precursor acute leukemia with tetraploidy

522

Myeloid-derived suppressor cell role in tumor-related inflammation

523

Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients

524

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

525

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

526

Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit+CD33−CD38− fraction of umbilical cord CD34+ cells

527

Myelolipomas and other fatty tumours of the adrenals

528

Myeloma aetiology and epidemiology

529

Myeloma appearance after local external beam radiotherapy jet: Is it a new entity?

530

Myeloma Ascites-A Favorable Outcome With Cyclophosphamide Therapy

531

Myeloma bone disease

532

Myeloma cells (5TMM) and their interactions with the marrow microenvironment

533

Myelomatous Pleural Effusion Case report and review of the literature

534

Myelomeningocele: Characterization of a surgically induced sheep model and its central nervous system similarities and differences to the human disease

535

Myelopathy due to hereditary multiple exostoses: CT and MR studies

536

Myelopathy following high voltage electrical injury: a case report

537

Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis

538

Myeloperoxidase −463G > A polymorphism and risk of primary lung cancer in a Korean population

539

Myeloperoxidase activity in chicken heterophils and adherent cells

540

Myeloperoxidase activity in chicken heterophils and adherent cells

541

Myeloperoxidase activity, fibrinogen concentrations and white blood cell counts in healthy and sick foals

542

Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure

543

Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography

544

Myeloperoxidase and Horseradish Peroxidase Catalyze Tyrosine Nitration in Proteins from Nitrite and Hydrogen Peroxide

545

Myeloperoxidase as a Biomarker in Acute Coronary Syndrome: Beware of the Pitfalls

546

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion

547

Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis?

548

Myeloperoxidase in Equine Semen: Concentration and Localization during Freezing Processing

549

Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia

550

Myeloperoxidase Levels in Patients with PCOS and/or Obesity Before and After Metformin Treatment

551

Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease

552

Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome

553

Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol Original Research Article

554

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss

555

Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients

556

Myeloperoxidase-catalyzed formation of PCDD/F from chlorophenols

557

Myeloperoxidase-Catalyzed Oxidation of Tyrosine

558

Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells

559

Myeloperoxidase-catalyzed taurine chlorination: Initial versus equilibrium rate

560

Myeloperoxidase-Dependent Generation of a Tyrosine Peroxide by Neutrophils

561

Myeloperoxidase-Dependent Loss of Malondialdehyde: A Limitation for Detecting Neutrophil-Mediated Lipid Peroxidation

562

Myeloperoxidase-generated oxidants and atherosclerosis

563

Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines

564

Myeloperoxidase-mediated oxidation of high-density lipoproteins: Fingerprints of newly recognized potential proatherogenic lipoproteins

565

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

566

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

567

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

568

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

569

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

570

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

571

Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates

572

Myeloproliferative disorders

573

Myeloproliferative disorders and its associated mutations

574

Myeloproliferative Neoplasm with Prominent Eosinophilia

575

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

576

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

577

Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice

578

Myeloprolipherative Disorder Type Chronic Myeloid Leucemia - Eosinophilic Form

579

Myeloprotection following cytotoxic damage: The sooner the better

580

Myeloprotective effect of Triticum aestivum Linn. grass against antineoplastic agents induced bone marrow toxicity in mice

581

Myenteric Denervation of the Gut with Benzalkonium Chloride: A Review of Forty Years of an Experimental Model

582

Myenteric denervation reduces the incidence of gastric tumors in rats

583

Myenteric plexus injury and apoptosis in experimental colitis

584

Myers effect and tachyon condensation Original Research Article

585

Myerson values for games with fuzzy communication structure

586

Myf-5 Revisited: Loss of Early Myotome Formation Does Not Lead to a Rib Phenotype in Homozygous Myf-5 Mutant Mice

587

Myhill–Nerode type theory for fuzzy languages and automata

588

589

Myiasis among slaughtered animals in Kashan, Iran: descriptive a veterinary entomological problem in the tropics

590

Myiasis in an 89-year-old man with non-hodgkin lymphoma.

591

Myiasis in Animals and Humans in Northeastern Anatolia

592

Myiasis of Mandible Due to Lucilia sericata, in Diabetic Woman Patient: A Case Report

593

Myiasis With Carcinoma in Situ of the Glans Penis: An Unusual Combination

594

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

595

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

596

Mylar™ and Teflon-AF™ as cell culture substrates for studying endothelial cell adhesion

597

MyLearningMentor: A Mobile App to Support Learners Participating in MOOCs

598

MyLifeBits: holding on to the present to preserve the past

599

Mylonite development in the Hercynian basement of Sardinia (Italy)

600

Mylonitic deformation of gabbro in the lower crust: A case study from the Pankenushi gabbro in the Hidaka metamorphic belt of central Hokkaido, Japan

601

Mylonitization in the lower plate of the Buckskin-Rawhide detachment fault, west-central Arizona: Implications for the geometric evolution of metamorphic core complexes

602

MyMessage: case-based reasoning and multicriteria decision making techniques for intelligent context-aware message filtering

603

Myo- and hepatotoxic effects of cultivated mushrooms in mice

604

MYO/ENDOTHELIAL DIFFERENTIATION OF HUMAN UMBILICAL CORD BLOOD-DERIVED STEM CELLS IN ISCHEMIC LIMB TISSUES

605

Myoblast alignment and differentiation on cell culture substrates with microscale topography and model chemistries

606

Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries

607

Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation

608

Myoblast transplantation for heart failure

609

Myoblast transplants challenged in muscular dystrophy

610

Myoblasts and fibroblasts in stress urinary incontinence

611

Myocardial 99m-Tc tetrofosmin reverse redistribution as a possible marker of tissue at risk

612

Myocardial abscess with contained rupture: successful repair

613

Myocardial adaptation and efficiency in response to intensive physical training in elite speedskaters

614

Myocardial adaptation to ischaemia – the preconditioning phenomenon

615

Myocardial adenine nucleotides, glycogen, and Na,K-ATPase in patients with idiopathic dilated cardiomyopathy requiring mechanical circulatory support

616

Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload

617

Myocardial and cerebral oxygen delivery are not adversely affected by cocaine administration to early-gestation fetal sheep, , ,

618

Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10

619

Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent

620

Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia

621

Myocardial and Systemic Iron Depletion in Heart Failure: Implications for Anemia Accompanying Heart Failure

622

Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients

623

Myocardial anti-ischemic effect of BRX-235: Role of nitric oxide and reactive oxygen species

624

Myocardial Apoptosis and Infarction after Ischemia/Reperfusion Are Attenuated by κ-Opioid Receptor Agonist

625

Myocardial apoptosis in heterotopic murine heart transplant model of chronic rejection/graft vasculopathy

626

Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study

627

Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Assist Device–Induced Myocardial Recovery

628

Myocardial atrophy in acquired immunodeficiency syndrome—associated wasting

629

Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X

630

Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months

631

Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy

632

Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition

633

Myocardial blood flow and coronary flow reserve late after anatomical correction of transposition of the great arteries

634

Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy

635

Myocardial blood supply by left ventricle-to-coronary artery channel: An old idea revisited

636

Myocardial blood-flow response during mental stress in patients with coronary artery disease

637

Myocardial bridge over the left anterior descending coronary artery: A case report and review of the literature

638

Myocardial Bridge: Surgical Outcome and Mid-term Follow up

639

Myocardial Bridging

640

Myocardial bridging causing transmural ischemia Successful coronary artery bypass surgery

641

Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease

642

Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome

643

Myocardial bridging in adult patients with hypertrophic cardiomyopathy

644

Myocardial bridging of coronary arteries: A risk factor for myocardial fibrosis?

645

Myocardial bridging of obtuse marginal branch of the left circumflex artery associated with congenital corrected transposition of the great arteries

646

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy

647

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply

648

Myocardial bridging of the posterolateral branches of the right coronary artery

649

Myocardial bridging of the ramus intermedius coronary artery

650

Myocardial bridging of the right coronary artery and emotional stress: A fatal link?

651

Myocardial bridging on left anterior descending coronary artery evaluated by multidetector computed tomography

652

Myocardial Bridging: Contemporary Understanding of Pathophysiology With Implications for Diagnostic and Therapeutic Strategies

653

Myocardial buffering capacity in ischemia preconditioned rat heads

654

Myocardial Capillaries and Coronary Flow Reserve

655

Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate

656

Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis

657

Myocardial cell damage in human hypertension

658

Myocardial Cell Death and Apoptosis in Hibernating Myocardium

659

Myocardial cell lineages in the mammalian embryo: The second heart field

660

Myocardial collagen and fibronectin levels in patients with pulmonary atresia and ventricular septal defect

661

Myocardial Connexin43 Expression in Left Ventricular Hypertrophy Resulting from Aortic Regurgitation

662

Myocardial contractile dispersion: A new marker for the severity of cirrhosis?

663

Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis

664

Myocardial Contractile Effects of image-Arginine in the Human Allograft

665

Myocardial Contractile Reserve Accurately Predicts Positive Response to Cardiac Resynchronization Therapy

666

Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy

667

Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy

668

Myocardial Contractile Responsiveness to Endothelin-1 in the Post-infarction Rat Model of Heart Failure: Effects of Chronic Quinapril

669

Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography

670

Myocardial contrast echo effect: The dilemm of coronary blood flow and volume

671

Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction

672

Myocardial Contrast Echocardiography Demonstrates That Collateral Flow Can Preserve Myocardial Function Beyond a Chronically Occluded Coronary Artery

673

Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far Review Article

674

Myocardial contrast echocardiography for the detection of coronary artery disease

675

Myocardial Contrast Echocardiography for the Detection of Coronary Artery Stenosis: A Prospective Multicenter Study in Comparison With Single-Photon Emission Computed Tomography Original Research Article

676

Myocardial contrast echocardiography in acute myocardial infarction

677

Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization Laboratory

678

Myocardial contrast echocardiography in human beings: Correlation of resting perfusion defects to sestamibi single photon emission computed tomography

679

Myocardial Contrast Echocardiography Perfusion Imaging: Still Waiting After All These Years

680

Myocardial contrast echocardiography to assess spontaneous reperfusion during myocardial infarction

681

Myocardial Contrast Echocardiography Versus Dobutamine Echocardiography for Predicting Functional Recovery After Acute Myocardial Infarction Treated With Primary Coronary Angioplasty

682

Myocardial Contrast Echocardiography Versus Thrombolysis in Myocardial Infarction Score in Patients Presenting to the Emergency Department With Chest Pain and a Nondiagnostic Electrocardiogram Original Research Article

683

Myocardial contrast echocardiography with a new calibration method can estimate myocardial viabilityin patients with myocardial infarction Original Research Article

684

Myocardial contrast echocardiography with power Doppler imaging

685

Myocardial contrast echocardiography, single-photon emission computed tomography, and regional function analysis for coronary stenosis description during vasodilator stress

686

Myocardial Contrast Echocardiography: An Innovative Technique to Assess Myocardial Perfusion in Hypertensive Patients

687

Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in canine model of coronary thrombosis and reperfusion

688

Myocardial contrast echocardiography: Reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent

689

Myocardial contrast versus dobutamine echocardiography as predictors of late functional recovery in acute myocardial infarction treated with primary PTC

690

Myocardial creatine kinase expression after left ventricular assist device support

691

Myocardial cytochrome c oxidase activity in Swedish moose (Alces alces L.) affected by molybdenosis

692

Myocardial damage after continuous aerobic and anaerobic exercise in rats

693

Myocardial Damage After TAVR Assessed With CMR: A New Piece in a Puzzle?

694

Myocardial damage and left ventricular dysfunction in patients with and without persistent negative t waves after q-wave anterior myocardial infarction

695

Myocardial damage and repair

696

Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure, ,

697

Myocardial damage in multisystem inflammatory syndrome associated with COVID‑19 in children and adolescents

698

Myocardial damage of the entire ventricular region in a patient with acute myocardial infarction

699

Myocardial Deformation and Rotational Profiles in Mitral Valve Prolapse

700

Myocardial deformation and ventricular vortices: physically-based imaging in clinical practice

701

Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction Original Research Article

702

Myocardial Deformation Imaging by Two-Dimensional Speckle-Tracking Echocardiography in Comparison to Late Gadolinium Enhancement Cardiac Magnetic Resonance for Analysis of Myocardial Fibrosis in Severe Aortic Stenosis

703

Myocardial Deformation Indices in Patients with Significant Aortic Regurgitation: A Strain Rate Imaging Study

704

Myocardial deformation recovery from cine MRI using a nearly incompressible biventricular model

705

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Chagas’ Disease: A Marker of Disease Severity Original Research Article

706

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy Original Research Article

707

Myocardial diastolic dysfunction at experimental diabetes mellitus—the role of nitric oxide

708

Myocardial disarray: an architectural disorganization linked with adrenergic stress?

709

Myocardial Distribution of Antegrade Cold Crystalloid and Tepid Blood Cardioplegia

710

Myocardial Doppler velocity imaging—a quantitative technique for interpretation of dobutamine echocardiography

711

Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning

712

Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus

713

Myocardial Dysfunction Caused by Perinatal Asphyxia in Full-term Infants

714

Myocardial Dysfunction in Thalassemia Major: Comparison between Echocardiography and MRI

715

Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of no, TNFα and sphingosine

716

Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse Model.

717

Myocardial dysfunction: hibernation and remodelling

718

Myocardial dysfunction: hibernation and remodelling

719

Myocardial edema: Comparison of effects on filling volume and stiffness of the left ventricle in rats and pigs

720

Myocardial effects of experimental acute brain death: Evaluation by hemodynamic and biological studies

721

Myocardial Effects of PDE5 Inhibition: More Function With Less Mass

722

Myocardial electrical impedance responds to ischemia and reperfusion in humans

723

Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease

724

Myocardial enterovirus infection with left ventricular dysfunction: benign disease compared with idiopathic dilated cardiomyopathy

725

Myocardial epithelial inclusions in a Holstein calf

726

Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?

727

Myocardial Expression of Endothelin-1 in Murine Trypanosoma cruzi Infection

728

Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy Original Research Article

729

Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat

730

Myocardial Extracellular Matrix Remodeling with the Development of Pacing Induced Congestive Heart Failure: Contributory Mechanisms

731

Myocardial Extracellular Remodeling Is Associated With Ventricular Diastolic Dysfunction in Children and Young Adults With Congenital Aortic Stenosis

732

Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy

733

Myocardial extramedullary hematopoiesis following myocardial infarction

734

Myocardial factor for timing of surgery in asymptomatic patients with mitral regurgitation

735

Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients

736

Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with

737

Myocardial Fibrosis Associated with Aldosterone or Angiotensin II Administration: Attenuation by Calcium Channel Blockade

738

Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels

739

Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation

740

Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone

741

Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice

742

Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death

743

Myocardial Flow Reserve in Long-Term Survivors of Repair of Anomalous Left Coronary Artery From Pulmonary Artery

744

Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair

745

Myocardial function and geometry in hypertensive subjects with low levels of afterload

746

Myocardial Function in Egyptian Pediatric Patients With Acute Nephritic Syndrome

747

Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5

748

Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone

749

Myocardial Function in the Working Mouse Heart Overexpressing Cardiac A1Adenosine Receptors

750

Myocardial Function of Horses Under Sedation with Romifidine Using Two-Dimensional Speckle Tracking

751

Myocardial Function of Hyperthyroid Rats in Presence of Diazepam in Langendorff Setup

752

Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging

753

Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders Original Research Article

754

Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease

755

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery Original Research Article

756

Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery Disease Original Research Article

757

Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and Ischemia

758

Myocardial Glycogen Depletion Cannot Explain the Cardioprotective Effects of Ischemic Preconditioning in the Rat Heart

759

Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload,

760

Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines

761

Myocardial Hydatid Cyst : An Uncommon Complication of Echinococcal Infection

762

Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review

763

Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats

764

Myocardial IL-6 regulation by neurohormones—an in vitro superfusion study

765

Myocardial imaging in patients with defibrillator patch electrodes

766

Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: Experimental studies in pigs

767

Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion

768

Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery

769

Myocardial infarction after an ice-hockey match: Coincidence of myocardial bridging and coronary spasm

770

Myocardial infarction after aspirin cessation in stable coronary artery disease patients

771

Myocardial Infarction after Endoscopic Removal of Foreign Body

772

Myocardial Infarction After Oral Sumatriptan Use in a Woman with Normal Coronary Arteries

773

Myocardial infarction after partial left ventriculectomy

774

Myocardial infarction after partial left ventriculectomy: Reply

775

Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging Original Research Article

776

Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia

777

Myocardial infarction and coronary care units

778

Myocardial infarction and depression: A review article

779

Myocardial infarction and heart failure—a dangerous intersection

780

Myocardial infarction and HELLP: a case of heightened vasomotor reactivity

781

Myocardial Infarction and Hyperglycemia

782

Myocardial infarction and ischemia

783

Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial

784

Myocardial infarction and percent arteriographic stenosis of culprit lesion: Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH) Original Research Article

785

Myocardial Infarction and Regulatory Myosin Light Chain

786

Myocardial infarction and sub-acute ventricular rupture: successful outcome in two cases

787

Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency

788

Myocardial infarction as a complication of new interventional devices

789

Myocardial infarction as complication of left atrial myxoma

790

Myocardial infarction caused by a large coronary artery aneurysm

791

Myocardial infarction caused by a leukemic clot: A case report

792

Myocardial Infarction Caused by Active-Fixation Ventricular Pacing Lead Screwed into the Anterior Descending Coronary Artery

793

Myocardial infarction caused by compression of the left coronary artery by an aortic pseudoaneurysm

794

Myocardial infarction caused by coronary artery myocardial bridge,

795

Myocardial infarction complicating the initial phase of an ovarian stimulation protocol

796

Myocardial infarction diagnosis by morphology of ventricular extrasystole

797

Myocardial infarction due to lightning strike

798

Myocardial infarction during menses: lessons from trials and errors

799

Myocardial infarction during scuba diving: A case report and review

800

Myocardial Infarction Elevates Inflammation and Contributes to the Formation of Atheroma Plaques in the Aorta of Hypercholesterolaemic Rats

801

Myocardial infarction following a bee sting

802

Myocardial infarction in a 35-day-old infant with incomplete Kawasaki disease and chicken pox

803

Myocardial Infarction in a newborn from a diabetic mother

804

Myocardial Infarction in a Patient with Prosthetic Aortic Valve

805

Myocardial infarction in a patient with thrombotic thrombocytopenic purpura

806

Myocardial infarction in a woman with no apparent risk factors

807

Myocardial infarction in a young athlete with non-obstructive hypertrophic cardiomyopathy and normal coronary arteries

808

Myocardial Infarction in a Young Patient After Acute Exposure to Carbon Monoxide

809

Myocardial infarction in a young woman with antiphospholipid syndrome

810

Myocardial infarction in children

811

Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis

812

Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI

813

Myocardial infarction in mice: Functional characterization and cytokine expression

814

Myocardial Infarction in Newly Diagnosed Hypertensive Medicaid Patients Free of Coronary Heart Disease and Treated with Calcium Channel Blockers

815

Myocardial Infarction in Patients with and without COVID-19: Comparisons of Characteristics, Clinical Courses, and Outcomes

816

Myocardial infarction in pregnant women — Case reports

817

Myocardial infarction in pre-war Leeds

818

Myocardial infarction in pre-war Leeds

819

Myocardial infarction in pre-war Leeds

820

Myocardial infarction in sickle-cell disease

821

Myocardial Infarction in the Absence of Obstructive Epicardial Coronary Disease

822

Myocardial infarction in the C57BL/6J mouse: A quantifiable and highly reproducible experimental model

823

Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)

824

Myocardial infarction in young adults: Angiographic characterization, risk factors, and prognosis (Coronary Artery Surgery Study registry): Zimmerman FH, Cameron A, Fisher LD, et al J Am Coll Cardiol 26:654–661 September 1995

825

Myocardial infarction in young patients

826

Myocardial Infarction Induced by Migraine Therapy

827

Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly

828

Myocardial infarction or inflammation?

829

Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study

830

Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement

831

Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner

832

Myocardial infarction redefined: Impact on case-load and outcome of patients with suspected acute coronary syndrome and nondiagnostic ECG at presentation

833

Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiolo

834

Myocardial Infarction Resulting From Caffeine Overdose in an Anorectic Woman, ,

835

Myocardial infarction resulting from nonatherosclerotic coronary artery diseases

836

Myocardial infarction risk in relation to zinc concentration in toenails

837

Myocardial infarction scar plication in the rat: cardiac mechanics in an animal model for surgical procedures

838

Myocardial Infarction Secondary to a Coronary Ostial Thrombus in Antiphospholipid Syndrome

839

Myocardial Infarction Secondary to Inflammatory Myofibroblastic Tumor Obstruction of the Left Main: Treated With Primary PCI

840

Myocardial infarction with huge mural thrombus due to spontaneous coronary artery dissection detected by 64-multidetector computed tomography

841

Myocardial infarction with spontaneous reperfusion in a young woman with hypertrophic cardiomyopathy

842

Myocardial infarction with thrombus formation during prolonged intense exercise

843

Myocardial infarction without coronary artery occlusion following mental stress

844

Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance

845

Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: Where we stand today

846

Myocardial Infarction, Viral Infection, and the Cytoskeleton: Final Common Pathways of a Common Disease?

847

Myocardial infarction: a catabolic disease?

848

Myocardial infarction: a paradigm of success in modern medicine

849

Myocardial infarction: a rare complication of dothiepin overdose

850

Myocardial infarction: changing view of a killer

851

Myocardial infarction: From trials to practice : Ball SG (editor) Wrightson Biomedical Publishing Ltd., Hampshire, UK, 1995; 194 pp.; stg£32.50; ISBN 1-871816-26-2

852

Myocardial infarction: is evidence-based medicine the best?

853

Myocardial Infarction-triggered Thrombotic Microangiopathy

854

Myocardial inflammatory infiltrate in human chronic chagasic cardiomyopathy: Immunohistochemical findings

855

Myocardial Injury After Electrical Therapy for Cardiac Arrhythmias Assessed by Troponin-T Release

856

Myocardial injury during off-pump surgery. The effect of intraoperative risk factors

857

Myocardial injury in thrombotic thrombocytopenic purpura: A frequent, perplexing complication

858

Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation

859

Myocardial injury-related changes in plasma NT-proBNP and ANP concentrations in a canine model of ischemic myocardial injury

860

Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapy

861

Myocardial integrated ultrasonic backscatter in patients with old myocardial infarction: Comparison with radionuclide evaluation

862

Myocardial involvement in a patient with human ehrlichiosis

863

Myocardial involvement in Takayasu arteritis

864

Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure: Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study

865

Myocardial iron load measured by cardiac magnetic resonance imaging to evaluate cardiac systolic function in thalassemia

866

Myocardial ischaemia

867

Myocardial ischaemia un-masked by transesophageal atrial pacing combined with two-dimensional transthoracic echocardiography in a pediatric patient: a case report

868

Myocardial ischaemia with a normal coronary angiogram due to the primary antiphospholipid syndrome

869

Myocardial Ischemia Activates the JAK–STAT Pathway Through Angiotensin II Signaling in in vivo Myocardium of Rats

870

Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients

871

Myocardial ischemia and infarction Review Article

872

Myocardial Ischemia and Infarction Review Article

873

Myocardial Ischemia and Infarction Review Article

874

Myocardial ischemia and reperfusion injury

875

Myocardial ischemia and ventricular fibrillation: Pathophysiology and clinical implications

876

Myocardial Ischemia and Ventricular Tachycardia on Continuous Electrocardiographic Monitoring and Risk of Cardiovascular Outcomes After Non–ST-Segment Elevation Acute Coronary Syndrome (from the MERLIN-TIMI 36 Trial)

877

Myocardial ischemia caused by a coronary anomaly left anterior descending coronary artery arising from right sinus of Valsalva

878

Myocardial Ischemia Caused by an Abnormal Origin and Course of the Left Coronary Artery in an Adult

879

Myocardial ischemia caused by cold-water submersion

880

Myocardial ischemia caused by external compression due to shotgun bullets

881

Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography

882

Myocardial ischemia during physical exercise in patients with stable coronary artery disease: predictability and prevention

883

Myocardial ischemia during sexual activity in patients with coronary artery disease

884

Myocardial ischemia in generalized coronary artery–left ventricular microfistulae

885

Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay: Insights From a Coronary Sinus Sampling Study

886

Myocardial ischemia induced by topical use of 5-fluorouracil

887

Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process

888

Myocardial Ischemic Injury and Purine Metabolism in Patients Undergoing Coronary Artery Bypass

889

Myocardial ischemic injury during cardiopulmonary by-pass: Evaluation of purine compounds by capillary electrophoresis

890

Myocardial ischemic post-conditioning protects the lung against myocardial ischemia/reperfusion-induced damage by activating GSK-3β

891

Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome

892

Myocardial kinematics from tagged MRI based on a 4-D B-spline model

893

Myocardial Kinetics of 99mTechnetium-Q Agents Studies in Isolated Cardiac Myocyte, Isolated Perfused Rat Heart, and Canine Regional Myocardial Ischemia Models

894

Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion

895

Myocardial lactate dehydrogenase subunit ratio in cardiac allograft recipients

896

Myocardial laser revascularization for the treatment of end-stage coronary artery disease

897

Myocardial laser revascularization: the controversy and the data

898

Myocardial Late Enhancement in Duchenne and Becker Individuals in the Clinical Milieu

899

Myocardial Metabolic Abnormality in a Primary Left Atrial Rhabdomyosarcoma: Localized 1H MR Spectroscopy

900

Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass

901

Myocardial Metabolism is Better Preserved After Blood Cardioplegia in Infants

902

Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy

903

Myocardial mitochondrial calcium accumulation modulates nuclear calcium accumulation and DNA fragmentation

904

Myocardial Motion Analysis From B-Mode Echocardiograms

905

Myocardial myotonia in myotonic muscular dystrophy

906

Myocardial necrosis in “pure unstable angina”: Identification of high-risk subgroups or a contradiction in terms?, ,

907

Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis

908

Myocardial No-Reflow in Humans

909

Myocardial outflow of prostacyclin in relation to metabolic stress during off-pump coronary artery bypass grafting

910

Myocardial Oxygen Consumption Modulates Adenosine Formation by Canine Right Ventricle in Absence of Hypoxia

911

Myocardial oxygen consumption: The quest for its determinants and some clinical fallout

912

Myocardial oxygen consumption: the quest for its determinants and some clinical fallout

913

Myocardial Oxygen Tension and Relative Capillary Density in Isolated Perfused Rat Hearts

914

Myocardial Oxygen Tension in Isolated Erythrocyte-perfused Rat Hearts and Comparison with Crystalloid Medi

915

Myocardial Oxygenation During Terminal Warm Blood Cardioplegia

916

Myocardial Oxygenation in Coronary Artery Disease: Insights From Blood Oxygen Level–Dependent Magnetic Resonance Imaging at 3 Tesla

917

Myocardial parasite persistence in chronic chagasic patients

918

Myocardial pathological changes in overtraining exercise

919

Myocardial perforation associated with the use of the Gensini ventriculography catheter

920

Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors

921

Myocardial performance after successful intervention for native aortic coarctation

922

Myocardial Performance after Successful Liver Transplantation

923

Myocardial perfusion abnormalities during low-dose dobutamine after coronary reperfusion can be demonstrated with intravenous perfluorocarbon-exposed sonicated dextrose albumin ultrasound contrast

924

Myocardial perfusion abnormality and necrosis in a patient with isolated noncompaction of the ventricular myocardium: Evaluation by myocardial perfusion SPECT and magnetic resonance imaging

925

Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction

926

Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up

927

Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy

928

Myocardial Perfusion and Ventricular Function Assessed by SPECT and Gated-SPECT in End-Stage Renal Disease Patients before and after Renal Transplant

929

Myocardial perfusion and viability by positron emission tomography in infants and children with coronary abnormalities: correlation with echocardiography,coronary angiography, and histopathology

930

Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography

931

Myocardial perfusion before and after single routine LDL-apheresis

932

Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study

933

Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

934

Myocardial Perfusion Imaging and Multidetector Computed Tomographic Coronary Angiography: Appropriate for All Patients With Suspected Coronary Artery Disease?

935

Myocardial Perfusion Imaging During Adenosine-Induced Coronary Hyperemia

936

Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon

937

Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention Review Article

938

Myocardial Perfusion Imaging Study of CO2-Induced Panic Attack

939

Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest Pain

940

Myocardial perfusion in apical ballooning syndrome: Correlate of myocardial injury

941

Myocardial perfusion in children with sickle cell disease

942

Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries

943

Myocardial perfusion in real-time using power modulation: In vivo evidence for microcirculatory damage after acute myocardial infarction

944

Myocardial perfusion magnetic resonance imaging for detecting coronary function anomalies in asymptomatic paediatric patients with a previous arterial switch operation for the transposition of great arteries

945

Myocardial Perfusion Magnetic Resonance Imaging Using Sliding-Window Conjugate-Gradient Highly Constrained Back-Projection Reconstruction for Detection of Coronary Artery Disease

946

Myocardial perfusion pattern in patients with cocaine-induced chest pain

947

Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy

948

myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging

949

Myocardial Perfusion Scintigraphy (Gated-SPECT) and Coronary Disease Risk Factors in Behçet’s Disease with Metabolic Syndrome

950

Myocardial Perfusion Scintigraphy and Value in Patients With Non-ST Segment Elevation Acute Coronary Syndromes

951

Myocardial perfusion single photon computed tomography: An Atlas

952

Myocardial perfusion SPECT and dobutamine stress tissue Doppler imaging in evaluation of patients with stable angina pectoris

953

Myocardial Perfusion SPECT Imaging in Dextrocardia with Situs Inversus: A Case Report

954

Myocardial perfusion SPECT: Perfusion quantification

955

Myocardial Perfusion Study of Panic Attacks in Patients With Coronary Artery Disease

956

Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers Original Research Article

957

Myocardial Preconditioning Produced by Ischemia, Hypoxia, and a KATPChannel Opener: Effects on Interstitial Adenosine in Dogs

958

Myocardial preservation during coronary surgery with and without cardiopulmonary bypass

959

Myocardial preservation using celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations

960

Myocardial protection

961

Myocardial protection and esmolol in blood perfused rat hearts

962

Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor

963

Myocardial protection during antegrade versus retrograde cardioplegia

964

Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy

965

Myocardial protection during reperfusion by administration of caspase-3 inhibitor is mediated via PI3 kinase survival pathway

966

Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases

967

Myocardial protection for acquired heart disease surgery: Results of a national survey

968

Myocardial protection for coronary bypass grafting: The Toronto Hospital perspective

969

Myocardial protection for neonatal cardiac surgery-the developmental status and ischemic damage in human heart cell

970

Myocardial protection in the immature heart

971

Myocardial Protection of Contractile Function After Global Ischemia by Physiologic Estrogen Replacement in the Ovariectomized Rat

972

Myocardial protection of the failing heart

973

Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning

974

Myocardial protection with endogenous overexpression of manganese superoxide dismutase

975

Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery

976

Myocardial protection with intermittent cross-clamp fibrillation: Improvement with sodium-hydrogen exchange inhibition

977

Myocardial protection with pinacidil cardioplegia in the blood-perfused heart

978

Myocardial protection with postconditioning is not enhanced by ischemic preconditioning

979

Myocardial protection with potassium-channel openers is as effective as St. Thomasʹ solution in the rabbit heart

980

Myocardial protection with Sevoflurane in Coronary Artery Bypass Grafting Surgery

981

Myocardial Protection with Simultaneous Antegrade/Vein Graft Cardioplegia Compared to Antegrade Cardioplegia Alone in Elective Coronary Artery Bypass Grafting Patients

982

MYOCARDIAL PROTECTION: A CLINICAL COMPARISON OF COLD BLOOD CARDIOPLEGIA AND COLD CRYSTALLOID CARDIOPLEGIA

983

Myocardial protection: Efficacy of RS-C (Aqix®), a novel magnesium-cardioplegia, compared to St Thomasʹ hospital solution

984

Myocardial protection: Modern studies

985

MYOCARDIAL PROTECTION: NEW STRATEGIES FOR PREVENTING LETHAL REFERFUSION INJURY

986

Myocardial protective efficacy of lidocaine (with or without adenosine) as agents to induce polarised cardioplegic arrest during global ischaemia in rat hearts

987

Myocardial recovery after mechanical support for acute myocarditis: is sustained recovery predictable?

988

Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target?

989

Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery: Effects of Short-Term Pre-Operative Statin Treatment

990

Myocardial regeneration by endogenous adult progenitor cells

991

Myocardial regeneration by human amniotic fluid stem cells: Challenges to be overcome

992

Myocardial Regeneration by Stem Cells: Seeing the Unseeable

993

Myocardial regeneration with bone-marrow-derived stem cells

994

Myocardial regeneration: Roles of stem cells and hydrogels

995

Myocardial Regenerative Therapy: Immunologic Basis for the Potential “Universal Donor Cells”

996

Myocardial remodeling differs between LV and RV myocardium from patients with idiopathic-dilated myocarditis, end-stage heart failure

997

Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5

998

Myocardial remodelling in a mouse model of diabetic cardiomyopathy

999

Myocardial response to ischemic preconditioning: is it a novel predictor of prognosis?

1000

Myocardial revascularisation after acute myocardial infarction

بازگشت